Latest news

Search
Categories
News archive

CEO Comment in Connection with the Preferential Rights Issue 2022

20 September, 2022

In 2022, Nanologica has taken important steps forward in the chromatography business area. We have scaled up the production of our commercial silica for preparative chromatography, NLAB Saga®, to tonal scale, and we have sold the first products in preparative chromatography, as well as taken orders for NLAB Saga® for production-scale evaluation from one of the world’s largest insulin manufacturers. The fact that we now have products from our large-scale production means that we can

Read more »

Nanologica Publishes Prospectus in Connection with Preferential Rights Issue

20 September, 2022

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES. The Board of Directors of Nanologica AB (publ) (“Nanologica” or the Company”) announced on 23 August 2022 that the Board of Directors has resolved

Read more »

Nanologica offentliggör prospekt med anledning av företrädesemission

20 September, 2022

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, I USA, AUSTRALIEN, JAPAN, KANADA, HONG KONG, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA, SYDKOREA ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING AV DETTA PRESSMEDDELANDE SKULLE VARA OLAGLIG ELLER KRÄVA YTTERLIGARE REGISTRERINGS- ELLER ANDRA ÅTGÄRDER. Styrelsen för Nanologica AB (publ) (”Nanologica” eller Bolaget”) offentliggjorde den 23 augusti 2022 att styrelsen beslutat att genomföra en företrädesemission av aktier motsvarande cirka 94 MSEK (”Företrädesemissionen”). Styrelsens

Read more »

Bulletin from the Extraordinary General Meeting of Nanologica AB (publ)

15 September, 2022

Nanologica AB (publ) held an extraordinary general meeting, where the following resolutions were passed. Resolution regarding approval of the board of directors’ resolution to issue shares with preferential rights for existing shareholders In accordance with previously announced information, the board of directors on August 23, 2022, resolved to issue new shares with preferential rights for the shareholders, subject to the extraordinary general meeting’s subsequent approval. The general meeting resolved, with the required majority, to approve

Read more »

Nanologica Receives Order for Silica for Preparative Chromatography

31 August, 2022

Nanologica AB (publ) has taken an order for the company’s silica for preparative chromatography at a value of approximately MSEK 1.3. The order comes from Nanologica’s partner in China, Yunbo Technology (Beijing) Co. Ltd. In July 2019, Nanologica signed an agreement with Chinese Yunbo Technology for the supply of silica for preparative chromatography worth approximately MUSD 14 (currently equivalent to approximately MSEK 150), between 2021 and 2026. The order that has now been placed is

Read more »